Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Prepaid Assets (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 5 years of Prepaid Assets data on record, last reported at $21.1 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 7.24% year-over-year to $21.1 million; the TTM value through Dec 2025 reached $21.1 million, up 7.24%, while the annual FY2025 figure was $21.1 million, 7.24% up from the prior year.
  • Prepaid Assets reached $21.1 million in Q4 2025 per ARQT's latest filing, up from $18.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $21.1 million in Q4 2025 and bottomed at $11.8 million in Q3 2022.
  • Average Prepaid Assets over 4 years is $17.1 million, with a median of $18.6 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: soared 107.1% in 2021, then increased 7.24% in 2025.
  • A 4-year view of Prepaid Assets shows it stood at $14.2 million in 2021, then dropped by 16.85% to $11.8 million in 2022, then skyrocketed by 66.8% to $19.7 million in 2024, then grew by 7.24% to $21.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $21.1 million in Q4 2025, $18.6 million in Q2 2025, and $19.7 million in Q4 2024.